A randomized, phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplatin for advanced, non-squamous, non-small cell lung cancer

A randomized, phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplatin for advanced, non-squamous, non-small cell lung cancer

<p>Abstract</p> <p>Background</p> <p>Maintenance therapy for non-small cell lung cancer (NSCLC) aims to extend disease control after first-line chemotherapy with active and well-tolerated agents. The utility of continuation maintenance therapy requires further research....

Full description

Bibliographic Details
Main Authors: Mubarak Nabil, Gaafar Rabab, Shehata Samir, Hashem Tarek, Abigeres Dani, Azim Hamdy A, El-Husseiny Gamal, Al-Husaini Hamed, Liu Zhixin
Format: Article
Language:English
Published: BMC 2012-09-01
Series:BMC Cancer
Subjects:
Non-squamous
Non-small cell lung cancer
Pemetrexed
Cisplatin
Induction
Maintenance
Online Access:http://www.biomedcentral.com/1471-2407/12/423

Internet

http://www.biomedcentral.com/1471-2407/12/423

Similar Items